Friday, June 15, 2012

Neuropsychopharmacology - Table of Contents alert Volume 37 Issue 8


TABLE OF CONTENTS

Volume 37, Issue 8 (July 2012)

In this issue
Commentaries
Original Articles
Corrigenda

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
SPECIAL FOCUS

The great strides in advancing resolution in genetic diagnosis, largely due to molecular techniques with nextgen sequencing as trailblazer, is fuelling the debate on the discordance between resolution and precision. Somewhere between those two lies the holy grail of patient benefit. Do we need to find everything, and can we, already?

Follow the debate on the EJHG web focus on Psychosocial aspects of advancing genetics
 

Commentaries

Top

Oxytocin and the Social Brain: Beware the Complexity

Andreas Bartels

Neuropsychopharmacology 2012 37: 1795-1796; 10.1038/npp.2012.71

Full Text

Commentary on ‘Reduced Subjective Response to Acute Ethanol Administration Among Young Men with a Broad Bipolar Phenotype’

Marc A Schuckit

Neuropsychopharmacology 2012 37: 1797-1798; 10.1038/npp.2012.61

Full Text

Original Articles

Top

Oxytocin Modulates Neural Reactivity to Children's Faces as a Function of Social Salience

Dina Wittfoth-Schardt, Johanna Gründing, Matthias Wittfoth, Heinrich Lanfermann, Markus Heinrichs, Gregor Domes, Anna Buchheim, Harald Gündel and Christiane Waller

Neuropsychopharmacology 2012 37: 1799-1807; advance online publication, April 18, 2012; 10.1038/npp.2012.47

Abstract | Full Text

Reduced Subjective Response to Acute Ethanol Administration Among Young Men with a Broad Bipolar Phenotype

Sarah W Yip, Joanne Doherty, Judi Wakeley, Kate Saunders, Charidimos Tzagarakis, Harriet de Wit, Guy M Goodwin and Robert D Rogers

Neuropsychopharmacology 2012 37: 1808-1815; advance online publication, April 11, 2012; 10.1038/npp.2012.45

Abstract | Full Text

Neurobiological Changes Mediating the Effects of Chronic Fluoxetine on Cocaine Use

Eileen K Sawyer, Jiyoung Mun, Jonathon A Nye, Heather L Kimmel, Ronald J Voll, Jeffrey S Stehouwer, Kenner C Rice, Mark M Goodman and Leonard L Howell

Neuropsychopharmacology 2012 37: 1816-1824; advance online publication, March 21, 2012; 10.1038/npp.2012.29

Abstract | Full Text

Sensitivity to Cognitive Effort Mediates Psychostimulant Effects on a Novel Rodent Cost/Benefit Decision-Making Task

Paul J Cocker, Jay G Hosking, James Benoit and Catharine A Winstanley

Neuropsychopharmacology 2012 37: 1825-1837; advance online publication, March 28, 2012; 10.1038/npp.2012.30

Abstract | Full Text

Novel Use of a Lipid-Lowering Fibrate Medication to Prevent Nicotine Reward and Relapse: Preclinical Findings

Leigh V Panlilio, Zuzana Justinova, Paola Mascia, Marco Pistis, Antonio Luchicchi, Salvatore Lecca, Chanel Barnes, Godfrey H Redhi, Jordan Adair, Stephen J Heishman, Sevil Yasar, Mano Aliczki, Jozsef Haller and Steven R Goldberg

Neuropsychopharmacology 2012 37: 1838-1847; advance online publication, March 28, 2012; 10.1038/npp.2012.31

Abstract | Full Text

Sex Modulates the Interactive Effect of the Serotonin Transporter Gene Polymorphism and Childhood Adversity on Hippocampal Volume

Daphne Everaerd, Lotte Gerritsen, Mark Rijpkema, Thomas Frodl, Iris van Oostrom, Barbara Franke, Guillén Fernández and Indira Tendolkar

Neuropsychopharmacology 2012 37: 1848-1855; advance online publication, March 21, 2012; 10.1038/npp.2012.32

Abstract | Full Text

A Novel Mechanism of Cocaine to Enhance Dopamine D2-Like Receptor Mediated Neurochemical and Behavioral Effects. An In Vivo and In Vitro Study

Luca Ferraro, Malgorzata Frankowska, Daniel Marcellino, Magdalena Zaniewska, Sarah Beggiato, Malgorzata Filip, Maria Cristina Tomasini, Tiziana Antonelli, Sergio Tanganelli and Kjell Fuxe

Neuropsychopharmacology 2012 37: 1856-1866; advance online publication, March 28, 2012; 10.1038/npp.2012.33

Abstract | Full Text

Aquaporin-4 Deficiency Impairs Synaptic Plasticity and Associative Fear Memory in the Lateral Amygdala: Involvement of Downregulation of Glutamate Transporter-1 Expression

Yan-Kun Li, Fang Wang, Wei Wang, Yi Luo, Peng-Fei Wu, Jun-Li Xiao, Zhuang-Li Hu, You Jin, Gang Hu and Jian-Guo Chen

Neuropsychopharmacology 2012 37: 1867-1878; advance online publication, April 4, 2012; 10.1038/npp.2012.34

Abstract | Full Text

The SSRI Citalopram Affects Fetal Thalamic Axon Responsiveness to Netrin-1 In vitro Independently of SERT Antagonism

Alexandre Bonnin, Le Zhang, Randy D Blakely and Pat Levitt

Neuropsychopharmacology 2012 37: 1879-1884; advance online publication, March 14, 2012; 10.1038/npp.2012.35

Abstract | Full Text

Genetic Dissection of the Role of Cannabinoid Type-1 Receptors in the Emotional Consequences of Repeated Social Stress in Mice

Sarah Dubreucq, Isabelle Matias, Pierre Cardinal, Martin Häring, Beat Lutz, Giovanni Marsicano and Francis Chaouloff

Neuropsychopharmacology 2012 37: 1885-1900; advance online publication, March 21, 2012; 10.1038/npp.2012.36

Abstract | Full Text

The Motivation to Self-Administer is Increased After a History of Spiking Brain Levels of Cocaine

Benjamin A Zimmer, Erik B Oleson and David CS Roberts

Neuropsychopharmacology 2012 37: 1901-1910; advance online publication, March 28, 2012; 10.1038/npp.2012.37

Abstract | Full Text

Activation of the Orexin 1 Receptor is a Critical Component of CO2-Mediated Anxiety and Hypertension but not Bradycardia

Philip L Johnson, Brian C Samuels, Stephanie D Fitz, Stafford L Lightman, Christopher A Lowry and Anantha Shekhar

Neuropsychopharmacology 2012 37: 1911-1922; advance online publication, March 28, 2012; 10.1038/npp.2012.38

Abstract | Full Text

Functional Connectivity in Brain Networks Underlying Cognitive Control in Chronic Cannabis Users

Ian H Harding, Nadia Solowij, Ben J Harrison, Michael Takagi, Valentina Lorenzetti, Dan I Lubman, Marc L Seal, Christos Pantelis and Murat Yücel

Neuropsychopharmacology 2012 37: 1923-1933; advance online publication, April 25, 2012; 10.1038/npp.2012.39

Abstract | Full Text

Reduced Tissue Levels of Noradrenaline Are Associated with Behavioral Phenotypes of the TgCRND8 Mouse Model of Alzheimer's Disease

Beverly M Francis, Jimao Yang, Enid Hajderi, Mary E Brown, Bernadeta Michalski, JoAnne McLaurin, Margaret Fahnestock and Howard T J Mount

Neuropsychopharmacology 2012 37: 1934-1944; advance online publication, April 11, 2012; 10.1038/npp.2012.40

Abstract | Full Text

Dopamine-Related Deficit in Reward Learning After Catecholamine Depletion in Unmedicated, Remitted Subjects with Bulimia Nervosa

Simona Grob, Diego A Pizzagalli, Sunny J Dutra, Jair Stern, Hanspeter Mörgeli, Gabriella Milos, Ulrich Schnyder and Gregor Hasler

Neuropsychopharmacology 2012 37: 1945-1952; advance online publication, April 11, 2012; 10.1038/npp.2012.41

Abstract | Full Text

Evidence that Behavioral Phenotypes of Morphine in β-arr2−/− Mice Are Due to the Unmasking of JNK Signaling

Nitish Mittal, Miao Tan, Onyemachi Egbuta, Nina Desai, Cynthia Crawford, Cui-Wei Xie, Christopher Evans and Wendy Walwyn

Neuropsychopharmacology 2012 37: 1953-1962; advance online publication, April 11, 2012; 10.1038/npp.2012.42

Abstract | Full Text

Acute Tryptophan Depletion Increases Translational Indices of Anxiety but not Fear: Serotonergic Modulation of the Bed Nucleus of the Stria Terminalis?

Oliver J Robinson, Cassie Overstreet, Phillip S Allen, Daniel S Pine and Christian Grillon

Neuropsychopharmacology 2012 37: 1963-1971; advance online publication, April 11, 2012; 10.1038/npp.2012.43

Abstract | Full Text

Corrigenda

Top

Dexamethasone Stimulated Gene Expression in Peripheral Blood is a Sensitive Marker for Glucocorticoid Receptor Resistance in Depressed Patients

Andreas Menke, Janine Arloth, Benno Pütz, Peter Weber, Torsten Klengel, Divya Mehta, Mariya Gonik, Monika Rex-Haffner, Jennifer Rubel, Manfred Uhr, Susanne Lucae, Jan M Deussing, Bertram Müller-Myhsok, Florian Holsboer and Elisabeth B Binder

Neuropsychopharmacology 2012 37: 1972; 10.1038/npp.2012.21

Full Text

Modulation of Social Influence by Methylphenidate

Daniel K Campbell-Meiklejohn, Arndis Simonsen, Mads Jensen, Victoria Wohlert, Trine Gjerløff, Jørgen Scheel-Kruger, Arne Møller, Chris D Frith and Andreas Roepstorff

Neuropsychopharmacology 2012 37: 1973; 10.1038/npp.2012.26

Full Text

Advertisement



The Arab world has a rich history of scientific breakthroughs. Become part of the scientific and medical community networking and exchanging information and ideas in the Nature Middle East Forum and House of Wisdom blog.

www.nature.com/nmiddleeast

Follow us: Facebook, Twitter, Google +
 

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: